NRx Pharmaceuticals, Inc.
NASDAQNRXP short interest surges 40% in one day to 11% of float, driven by heavy borrowing demand and 70% utilization.
Short interest % of float, cost to borrow, utilization, and put/call ratio for NRXP are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 7 May 2026
No long-form analysis yet for NRXP. Pulse alerts and the live data picture are available on ORTEX.
Open NRXP on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NRXP — free to start on ORTEX.
Sign up for free →Open NRXP on ORTEX